The deal combines Stereotaxis’ magnetic navigation technology and Robocath’s mechanical robotic system, strengthening Stereotaxis’ position in endovascular surgery, said CEO David Fischel.
Stereotaxis says the acquisition strengthens its position as “a leading platform for the full spectrum of endovascular ...
Non-surgical venous thrombectomy now available; walking, exercise key to prevention Dr K.K. Pandey If you suddenly begin to ...
Lahey Hospital & Medical Center’s Cardiovascular Medicine Department has embraced using interventional cardiology to treat ...
Adding a balloon or stent procedure (endovascular angioplasty to widen blood vessels in the neck) to standard treatment may make little to no difference to the chance of another stroke or mini-stroke ...
Detailed price information for Stereotaxis Inc (STXS-A) from The Globe and Mail including charting and trades.
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced ...
Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced that initial patients have been enrolled in the ADAPT ...
Morning Overview on MSN
Colorado surgeons implant higher-brain BCI in claimed world first
A surgical team at UCHealth University of Colorado Hospital has implanted a brain-computer interface in a region of the brain ...
Oklahoma Children’s Hospital at OU Health has performed the state’s first targeted chemotherapy for retinoblastoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results